Developments in nonsteroidal antiandrogens targeting the androgen receptor.
Liu
Bo
B
School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, People's Republic of China.
Su
Lei
L
Geng
Jingkun
J
Liu
Junjie
J
Zhao
Guisen
G
D059002:Androgen Receptor Antagonists / Q000737:chemistry*; D000813:Anilides / Q000737:chemistry / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000737:chemistry*; D006801:Humans; D006827:Hydantoins / Q000737:chemistry / Q000494:pharmacology; D007094:Imides / Q000737:chemistry / Q000494:pharmacology; D008297:Male; D009570:Nitriles / Q000737:chemistry / Q000494:pharmacology; D009942:Organometallic Compounds / Q000737:chemistry / Q000494:pharmacology; D010081:Oxazolone / Q000737:chemistry / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000378:metabolism; D011725:Pyridines / Q000737:chemistry / Q000494:pharmacology; D011758:Pyrroles / Q000737:chemistry / Q000494:pharmacology; D011944:Receptors, Androgen / Q000737:chemistry* / Q000378:metabolism; D014105:Tosyl Compounds / Q000737:chemistry / Q000494:pharmacology
D059002:Androgen Receptor Antagonists; D000813:Anilides; D000970:Antineoplastic Agents; D006827:Hydantoins; D007094:Imides; D009570:Nitriles; D009942:Organometallic Compounds; D011725:Pyridines; D011758:Pyrroles; D011944:Receptors, Androgen; D014105:Tosyl Compounds; D010081:Oxazolone; C053541:bicalutamide